{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:52:18Z","timestamp":1772639538027,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.antiviral.2014.04.004","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T06:18:21Z","timestamp":1398320301000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers"],"prefix":"10.1016","volume":"107","author":[{"given":"Chee Wah","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoke Fun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Wan","family":"Quah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chit Laa","family":"Poh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.04.004_b0005","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1099\/vir.0.2008\/002915-0","article-title":"Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity","volume":"89","author":"Arita","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virusres.2008.07.001","article-title":"Divergent picornavirus IRES elements","volume":"139","author":"Belsham","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0015","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4161\/hv.21739","article-title":"Production of EV71 vaccine candidates","volume":"8","author":"Chong","year":"2012","journal-title":"Hum. Vaccine Immunother."},{"key":"10.1016\/j.antiviral.2014.04.004_b0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1076\/ocii.7.3.189.4007","article-title":"Fomivirsen \u2013 a phosphorothioate oligonucleotide for the treatment of CMV retinitis","volume":"7","author":"de Smet","year":"1999","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.antiviral.2014.04.004_b0025","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1128\/JVI.79.8.4599-4609.2005","article-title":"Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication","volume":"79","author":"Deas","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1423-0127-19-73","article-title":"The highly conserved 5\u2019 untranslated region as an effective target towards the inhibition of enterovirus 71 replication by unmodified and appropriate 2\u2019-modified siRNAs","volume":"19","author":"Deng","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2014.04.004_b0035","first-page":"347","article-title":"Antisense oligonucleotides: basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.antiviral.2014.04.004_b0040","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/AAC.00644-06","article-title":"Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers","volume":"50","author":"Ge","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.04.004_b0045","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1128\/JVI.79.8.5116-5128.2005","article-title":"Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers","volume":"79","author":"Kinney","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrd3625","article-title":"RNA therapeutics: beyond RNA interference and antisense oligonucleotides","volume":"11","author":"Kole","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2014.04.004_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/nar\/gkn901","article-title":"Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation","volume":"37","author":"Lin","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0060","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1128\/JVI.02476-08","article-title":"HnRNP A1 interacts with the 5\u2019 untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication","volume":"83","author":"Lin","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2009.07.020","article-title":"Inhibition of herpes simplex virus 1 ocular infection with morpholino oligomers targeting ICP0 and ICP27","volume":"84","author":"Moerdyk-Schauwecker","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0070","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/molecules14031304","article-title":"Gene knockdowns in adult animals: PPMOs and vivo-morpholinos","volume":"14","author":"Moulton","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2014.04.004_b0075","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1128\/JVI.78.11.5891-5899.2004","article-title":"Antisense morpholino-oligomers directed against the 5\u2019 end of the genome inhibit coronavirus proliferation and growth","volume":"78","author":"Neuman","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0080","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","article-title":"Clinical features, diagnosis, and management of enterovirus 71","volume":"9","author":"Ooi","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2011.04.012","article-title":"Inhibition of porcine reproductive and respiratory syndrome virus infection in piglets by a peptide-conjugated morpholino oligomer","volume":"91","author":"Opriessnig","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virol.2008.03.032","article-title":"Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers","volume":"376","author":"Paessler","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.04.004_b0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2007.09.002","article-title":"Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication","volume":"77","author":"Patel","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.antiviral.2012.12.010","article-title":"Development and characterization of a stable eGFP enterovirus 71 for antiviral screening","volume":"97","author":"Shang","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2012.12.005","article-title":"Antiviral drug discovery for the treatment of enterovirus 71 infections","volume":"97","author":"Shang","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0110","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1128\/JVI.05063-11","article-title":"Host factors in enterovirus 71 replication","volume":"85","author":"Shih","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0115","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/AAC.48.9.3523-3529.2004","article-title":"Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone","volume":"48","author":"Shih","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.04.004_b0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2005.06.047","article-title":"RNA interference against enterovirus 71 infection","volume":"341","author":"Sim","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.04.004_b0125","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.04.004_b0130","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1128\/AAC.00011-08","article-title":"A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus","volume":"52","author":"Stone","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.04.004_b0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-4781(99)00150-5","article-title":"Morpholino antisense oligomers: the case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2014.04.004_b0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/eri.13.47","article-title":"Enterovirus 71 receptors: promising drug targets?","volume":"11","author":"Tan","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.antiviral.2014.04.004_b0145","doi-asserted-by":"crossref","first-page":"e34589","DOI":"10.1371\/journal.pone.0034589","article-title":"Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.04.004_b0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1423-0127-21-14","article-title":"Recent developments in antiviral agents against enterovirus 71 infection","volume":"21","author":"Tan","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2014.04.004_b0155","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/JVI.02226-12","article-title":"Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor","volume":"87","author":"Tan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2007.01.004","article-title":"Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71","volume":"74","author":"Tan","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0165","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.mt.6300287","article-title":"Inhibition of enterovirus 71 in virus-infected mice by RNA interference","volume":"15","author":"Tan","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2014.04.004_b0170","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1128\/JVI.00557-07","article-title":"Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers","volume":"81","author":"Vagnozzi","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0175","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.ppat.0020001","article-title":"Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers","volume":"2","author":"Warfield","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.04.004_b0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2012.02.004","article-title":"Advanced morpholino oligomers: a novel approach to antiviral therapy","volume":"94","author":"Warren","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.04.004_b0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jviromet.2009.04.002","article-title":"Identification of small interfering RNAs which inhibit the replication of several enterovirus 71 strains in China","volume":"159","author":"Wu","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2014.04.004_b0190","doi-asserted-by":"crossref","first-page":"e27082","DOI":"10.1371\/journal.pone.0027082","article-title":"A single nucleotide in stem loop II of 5\u2019-untranslated region contributes to virulence of enterovirus 71 in mice","volume":"6","author":"Yeh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.04.004_b0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc060138s","article-title":"Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells","volume":"18","author":"Youngblood","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.antiviral.2014.04.004_b0200","doi-asserted-by":"crossref","first-page":"11510","DOI":"10.1128\/JVI.00900-06","article-title":"Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site","volume":"80","author":"Yuan","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.04.004_b0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2008.08.044","article-title":"Co-selection of West Nile virus nucleotides that confer resistance to an antisense oligomer while maintaining long-distance RNA\/RNA base pairings","volume":"382","author":"Zhang","year":"2008","journal-title":"Virology"}],"updated-by":[{"DOI":"10.1016\/j.antiviral.2014.08.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000}}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T05:50:16Z","timestamp":1656222616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":41,"alternative-id":["S0166354214001107"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.04.004","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.antiviral.2014.08.001","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}